Search

Your search keyword '"Aguillon, Juan C"' showing total 14 results
Start Over Author "Aguillon, Juan C"
14 results on '"Aguillon, Juan C"'

3. Minimum information about tolerogenic antigen-presenting cells (MITAP): a first step towards reproducibility and standardisation of cellular therapies

Author

Lord, Phillip, Aguillon, Juan C, Anderson, Amy E, Appel, Silke, Benitez-Ribas, Daniel, Ten Brinke, Anja, Broere, Femke, Cools, Nathalie, Cuturi, Maria Cristina, Diboll, Julie, Geissler, Edward K, Giannoukakis, Nick, Gregori, Silvia, van Ham, S Marieke, Lattimer, Staci, Marshall, Lindsay, Harry, Rachel A, Hutchinson, James A, Isaacs, John D, Joosten, Irma, van Kooten, Cees, Lopez Diaz de Cerio, Ascension, Nikolic, Tatjana, Oral, Haluk Barbaros, Sofronic-Milosavljevic, Ljiljana, Ritter, Thomas, Riquelme, Paloma, Thomson, Angus W, Trucco, Massimo, Vives-Pi, Marta, Martinez-Caceres, Eva M, Hilkens, Catharien M U, Lord, Phillip, Aguillon, Juan C, Anderson, Amy E, Appel, Silke, Benitez-Ribas, Daniel, Ten Brinke, Anja, Broere, Femke, Cools, Nathalie, Cuturi, Maria Cristina, Diboll, Julie, Geissler, Edward K, Giannoukakis, Nick, Gregori, Silvia, van Ham, S Marieke, Lattimer, Staci, Marshall, Lindsay, Harry, Rachel A, Hutchinson, James A, Isaacs, John D, Joosten, Irma, van Kooten, Cees, Lopez Diaz de Cerio, Ascension, Nikolic, Tatjana, Oral, Haluk Barbaros, Sofronic-Milosavljevic, Ljiljana, Ritter, Thomas, Riquelme, Paloma, Thomson, Angus W, Trucco, Massimo, Vives-Pi, Marta, Martinez-Caceres, Eva M, and Hilkens, Catharien M U

Abstract

Cellular therapies with tolerogenic antigen-presenting cells (tolAPC) show great promise for the treatment of autoimmune diseases and for the prevention of destructive immune responses after transplantation. The methodologies for generating tolAPC vary greatly between different laboratories, making it difficult to compare data from different studies; thus constituting a major hurdle for the development of standardised tolAPC therapeutic products. Here we describe an initiative by members of the tolAPC field to generate a minimum information model for tolAPC (MITAP), providing a reporting framework that will make differences and similarities between tolAPC products transparent. In this way, MITAP constitutes a first but important step towards the production of standardised and reproducible tolAPC for clinical application.

Published
2016

4. Minimum information about tolerogenic antigen-presenting cells (MITAP): a first step towards reproducibility and standardisation of cellular therapies

Author

LS Immunologie, dI&I RA-I&I I&I, Lord, Phillip, Aguillon, Juan C, Anderson, Amy E, Appel, Silke, Benitez-Ribas, Daniel, Ten Brinke, Anja, Broere, Femke, Cools, Nathalie, Cuturi, Maria Cristina, Diboll, Julie, Geissler, Edward K, Giannoukakis, Nick, Gregori, Silvia, van Ham, S Marieke, Lattimer, Staci, Marshall, Lindsay, Harry, Rachel A, Hutchinson, James A, Isaacs, John D, Joosten, Irma, van Kooten, Cees, Lopez Diaz de Cerio, Ascension, Nikolic, Tatjana, Oral, Haluk Barbaros, Sofronic-Milosavljevic, Ljiljana, Ritter, Thomas, Riquelme, Paloma, Thomson, Angus W, Trucco, Massimo, Vives-Pi, Marta, Martinez-Caceres, Eva M, Hilkens, Catharien M U, LS Immunologie, dI&I RA-I&I I&I, Lord, Phillip, Aguillon, Juan C, Anderson, Amy E, Appel, Silke, Benitez-Ribas, Daniel, Ten Brinke, Anja, Broere, Femke, Cools, Nathalie, Cuturi, Maria Cristina, Diboll, Julie, Geissler, Edward K, Giannoukakis, Nick, Gregori, Silvia, van Ham, S Marieke, Lattimer, Staci, Marshall, Lindsay, Harry, Rachel A, Hutchinson, James A, Isaacs, John D, Joosten, Irma, van Kooten, Cees, Lopez Diaz de Cerio, Ascension, Nikolic, Tatjana, Oral, Haluk Barbaros, Sofronic-Milosavljevic, Ljiljana, Ritter, Thomas, Riquelme, Paloma, Thomson, Angus W, Trucco, Massimo, Vives-Pi, Marta, Martinez-Caceres, Eva M, and Hilkens, Catharien M U

Published
2016

5. Minimum information about tolerogenic antigen-presenting cells (MITAP): a first step towards reproducibility and standardisation of cellular therapies

Author

Lord, Phillip, primary, Spiering, Rachel, additional, Aguillon, Juan C., additional, Anderson, Amy E., additional, Appel, Silke, additional, Benitez-Ribas, Daniel, additional, ten Brinke, Anja, additional, Broere, Femke, additional, Cools, Nathalie, additional, Cuturi, Maria Cristina, additional, Diboll, Julie, additional, Geissler, Edward K., additional, Giannoukakis, Nick, additional, Gregori, Silvia, additional, van Ham, S. Marieke, additional, Lattimer, Staci, additional, Marshall, Lindsay, additional, Harry, Rachel A., additional, Hutchinson, James A., additional, Isaacs, John D., additional, Joosten, Irma, additional, van Kooten, Cees, additional, Lopez Diaz de Cerio, Ascension, additional, Nikolic, Tatjana, additional, Oral, Haluk Barbaros, additional, Sofronic-Milosavljevic, Ljiljana, additional, Ritter, Thomas, additional, Riquelme, Paloma, additional, Thomson, Angus W., additional, Trucco, Massimo, additional, Vives-Pi, Marta, additional, Martinez-Caceres, Eva M., additional, and Hilkens, Catharien M.U., additional

Published
2016
Full Text
View/download PDF

11. Established Murine Collagen-induced Arthritis and IL-17 Production are Specifically Inhibited by a Single Inoculation of Lipopolysaccharide-stimulated Dendritic Cells

Author

Aguillon, Juan C., primary, Salazar, Lorena, additional, Aravena, Octavio, additional, Gonzalez, Carlos, additional, Abello, Paula, additional, Contreras-Levicoy, Juan, additional, Pesce, Barbara, additional, Salazar-Onfray, Flavi, additional, and Cuchacovich, Miguel, additional

Published
2007
Full Text
View/download PDF

14. Minimum information about tolerogenic antigen-presenting cells (MITAP): a first step towards reproducibility and standardisation of cellular therapies

Author

Lord, Phillip, Spiering, Rachel, Aguillon, Juan C., Anderson, Amy E., Appel, Silke, Benitez-Ribas, Daniel, ten Brinke, Anja, Broere, Femke, Cools, Nathalie, Cuturi, Maria Cristina, Diboll, Julie, Geissler, Edward K., Giannoukakis, Nick, Gregori, Silvia, van Ham, S. Marieke, Lattimer, Staci, Marshall, Lindsay, Harry, Rachel A., Hutchinson, James A., Isaacs, John D., Joosten, Irma, van Kooten, Cees, Lopez Diaz de Cerio, Ascension, Nikolic, Tatjana, Oral, Haluk Barbaros, Sofronic-Milosavljevic, Ljiljana, Ritter, Thomas, Riquelme, Paloma, Thomson, Angus W., Trucco, Massimo, Vives-Pi, Marta, Martinez-Caceres, Eva M., and Hilkens, Catharien M. U.

Subjects
610 Medizin, DENDRITIC CELLS, DISEASE, Cell therapy, Minimum information model, Antigen-presenting cells, Autoimmune disease, Transplantation, Tolerogenic dendritic cells, Regulatory macrophages, Reporting guidelines, 3. Good health
Abstract

Cellular therapies, with tolerogenic antigen-presenting cells (tolAPC) show great promise for the treatment of autoimmune diseases and for the prevention of destructive immune responses after transplantation The methodologies for generating tolAPC vary greatly between different laboratories, making it difficult to compare data from different studies; thus constituting a major hurdle for the development of standardised tolAPC therapeutic products. Here we describe an initiative by members of the tolAPC field to generate a minimum information model for tolAPC (MITAP), providing a reporting framework that will make differences and similarities between tolAPC products transparent. In this way, MITAP constitutes a first but important step towards the production of standardised and reproducible tolAPC for clinical application.

Catalog

Books, media, physical & digital resources
See catalog results